CSIMarket


Transmedics Group Inc   (TMDX)
Other Ticker:  
 


 

Transmedics Group Inc

TMDX's Financial Statements and Analysis



Transmedics Group Inc increased third quarter of 2023 net loss per share of $-0.78 compare to net loss per share of $-0.25 recorded in the same quarter a year ago a decrease compare to $-0.03 realized in previous quarter.


third quarter of 2023
Earnings Per Share Revenues
$ -0.78 $  66 Mill
$-0.53     $+41M     +158.65 %



Transmedics Group Inc 's Revenue rose by 158.65 % in third quarter of 2023 (Sep 30 2023) year on year, to $66 million and advanced by 26.62 % sequentially.


Transmedics Group Inc is

More on TMDX's Income Statement



Transmedics Group Inc 's in thethird quarter of 2023 recorded net loss of $-25.422 million, an increase from net loss of $-7.426 million in III. Quarter a year ago.

Sequentially net loss advanced

More on TMDX's Growth

Transmedics Group Inc Inventories
Inventories grew by 111.92 % to $39 million from III. Quarter a year ago, sequentially inventories rose by 28.88 %. In Sep 30 2023 company's net cash and cash equivalents decreased by $-155 million, capital expenditures fell by -2.933,576.52%, to $-108 millions compare to same quarter a year ago

More on TMDX's Cash flow Statement


Transmedics Group Inc does not pay out common stock dividend.

In trailing twelve-month period Transmedics Group Inc payed $ -0.78 cash per share, on a free-cash flow basis .

Book value fell by -13.10 % sequentially to $3.88 per share, -53.90% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value fell to $ 3.45 per share from $ 4.46.

Company issued 0.07 million shares or 0.21 % in Sep 30 2023.


More on TMDX's Dividends

 Market Capitalization (Millions) 2,429
 Shares Outstanding (Millions) 33
 Total Debt (Millions $) 505
 Revenue (TTM) (Millions $) 192
 Net Income (TTM) (Millions $) -36
 Cash Flow (TTM) (Millions $) 223
 Capital Exp. (TTM) (Millions $) -113
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 194




Transmedics Group Inc does not pay out common stock dividend.

In trailing twelve-month period Transmedics Group Inc had negative $ -0.78 cash flow per share, on a free-cash flow basis .

Book value fell by -13.10 % sequentially to $3.88 per share, -53.90% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value fell to $ 3.45 per share from $ 4.46.

Company issued 0.07 million shares or 0.21 % in Sep 30 2023.


More on TMDX's Balance Sheets

 Market Capitalization (Millions) 2,429
 Shares Outstanding (Millions) 33
 Total Debt (Millions $) 505
 Revenue (TTM) (Millions $) 192
 Net Income (TTM) (Millions $) -36
 Cash Flow (TTM) (Millions $) 223
 Capital Exp. (TTM) (Millions $) -113
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 194
   


  News about Transmedics Group Inc Earnings

TMDX Struggles to Achieve Profitability Despite Remarkable Revenue Surge

Transmedics Group Inc, a leading player in the Medical Equipment and Supplies sector, has recently announced robust financial results for the third quarter of 2023. Their revenue recorded an impressive growth of 158.654% year on year, amounting to $66.43 million during the July to September period. However, shareholders were disheartened by the increased shortfall per share, reaching $-0.78.
In comparison to its peers in the Medical Equipment and Supplies sector, Transmedics Group Inc experienced a considerably higher growth rate in top-line revenue. The average top-line growth for the two third businesses in this sector was merely 4.49% relative to the same period last year. This indicates that Transmed...

Transmedics Group Inc Shatters Expectations with Stupendous 155% Growth in Q2 of 2023!

Exciting Growth and Promising Future for Transmedics Group Inc in the Stock Market
Transmedics Group Inc, a leading medical device company, has recently announced its financial results for the second quarter of 2023, and the numbers are truly impressive. Investors have every reason to be excited about the stock market potential of this innovative company.
One of the most remarkable achievements for Transmedics Group Inc is the significant reduction in loss per share compared to the previous year. In Q2 2023, the company decreased its loss per share to $-0.03, a substantial improvement from $-0.41 a year ago. This indicates a tremendous shift towards profitability and demonstrates the company's abilit...

Transmedics Group Inc Makes Stunning Turnaround, Erasing Deficit in Recent Fiscal Period

The stock market is a volatile space, and investors should approach it wi...


Date modified: 2023-11-10T00:15:37+00:00





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com